Protease inhibitors enhance levodopa effects in Parkinson's disease [2]

Movement Disorders

Volumn 14, Issue 3, 1999, Pages 535-

  Caparros Lefebvre, Dominique ^a   Lannuzel, Annie ^a   Tiberghien, François ^a   Strobel, Michel ^b  

^a Department of Neurology   (France)

^b Centre Hospitalier Universitaire Pointe a Pitre   (Guadeloupe)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOCHROME P450; DOPA DECARBOXYLASE INHIBITOR; INDINAVIR; LAMIVUDINE; LEVODOPA; PROTEINASE INHIBITOR; ZIDOVUDINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; AGED; CASE REPORT; DYSKINESIA; HUMAN; LETTER; MOTOR DYSFUNCTION; PARKINSON DISEASE; PRIORITY JOURNAL;

ANTIPARKINSON AGENTS; CASE REPORT; DRUG SYNERGISM; DYSKINESIA, DRUG-INDUCED; HIV PROTEASE INHIBITORS; HUMAN; INDINAVIR; LEVODOPA; MALE; MIDDLE AGE; PARKINSON DISEASE;

EID: 0033406126     PISSN: 08853185     EISSN: None     Source Type: Journal    
DOI: 10.1002/1531-8257(199905)14:3<535::AID-MDS1034>3.0.CO;2-S     Document Type: Letter

References (6)